Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14701 - 14725 of 14989 in total
Experimental
Experimental
LI 301 is an orally bio-available compound delivered in a fast melt mechanism with taste masking enabling it to be taken anytime without water. It has a novel mode of action combining both the light effect of a Selective Serotonin Reuptake Inhibitor ("SSRI")(most likely antagonistic at 5HT1a receptors) and antagonism...
Investigational
Matched Description: … of a Selective Serotonin Reuptake Inhibitor ("SSRI")(most likely antagonistic at 5HT1a receptors) and
TPMPA ((1,2,5,6-tetrahydropyridine-4-yl)methylphosphinic acid) is a selective antagonist of GABAC receptors (also known as GABA-ρ or GABAA-ρ receptors). GABAC receptors are found primarily in the retina, although they may be present in other tissues, including the hippocampus, spinal cord, superior colliculus, pituitary and the gut.[A245308,A245313] TPMPA is used as a pharmacological...
Experimental
Matched Description: … be present in other tissues, including the hippocampus, spinal cord, superior colliculus, pituitary and
BMS-903452 has been used in trials studying the treatment of Diabetes.
Investigational
Imiglitazar has been used in trials studying the treatment of Diabetes Mellitus.
Investigational
E6005 has been used in trials studying the treatment of Atopic Dermatitis.
Investigational
Investigational
Experimental
Investigational
Displaying drugs 14701 - 14725 of 14989 in total